Veterinary Medicines

PHARMAVAC PHA emulsion for injection for pigeons

Authorised
  • Pigeon paramyxovirus 1, strain 988M, Inactivated
  • Pigeon herpesvirus, strain V298/70, Inactivated
  • Fowl aviadenovirus 8, strain M2/E, Inactivated
Download as PDF

Product identification

Medicine name:
PHARMAVAC PHA emulsion for injection for pigeons
Pharmavac PHA Emulsie voor injectie
Pharmavac PHA Emulsion injectable
Pharmavac PHA Emulsion zur Injektion
Active substance:
  • Pigeon paramyxovirus 1, strain 988M, Inactivated
  • Pigeon herpesvirus, strain V298/70, Inactivated
  • Fowl aviadenovirus 8, strain M2/E, Inactivated
Target species:
  • Pigeon
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Pigeon paramyxovirus 1, strain 988M, Inactivated
    6.90
    log2 haemagglutination inhibiting unit(s)
    /
    0.30
    millilitre(s)
  • Pigeon herpesvirus, strain V298/70, Inactivated
    38.10
    enzyme-linked immunosorbent assay unit
    /
    0.30
    millilitre(s)
  • Fowl aviadenovirus 8, strain M2/E, Inactivated
    24.70
    enzyme-linked immunosorbent assay unit
    /
    0.30
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pigeon
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01EA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Paper carton containing one glass vial, type I closed with chlorobutyl rubber stopper sealed with aluminium cap

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharmagal Bio spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmagal Bio spol. s r.o.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V538355
Date of authorisation status change:
Reference member state:
  • Slovakia
Procedure number:
  • SK/V/0108/001
Concerned member states:
  • Belgium
  • Czechia
  • Germany
  • Hungary
  • Netherlands
  • Poland

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."